Mayne Pharma drugs
6 results
Fabior (tazarotene)
(tazarotene)Mayne Pharma
Usage: FABIOR® (tazarotene) Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients aged 12 years and older.
Lexette (halobetasol propionate)
(Halobetasol propionate)Mayne Pharma
Usage: LEXETTE® is indicated for the topical treatment of plaque psoriasis in patients aged 12 years and older.
Methylphenidate hydrochloride (la) (methylphenidate hydrochloride)
(Methylphenidate Hydrochloride)Mayne Pharma
Usage: Methylphenidate hydrochloride extended-release capsules (LA) are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients aged 6 to 12 years.
Nextstellis (drospirenone and estetrol)
(drospirenone and estetrol)Mayne Pharma
Usage: NEXTSTELLIS is indicated for pregnancy prevention in females of reproductive potential. Its effectiveness may be reduced in those with a BMI of 30 kg/m² or higher, with decreased effectiveness correlating with increasing BMI.
Rhofade (oxymetazoline hydrochloride)
(oxymetazoline hydrochloride)Mayne Pharma
Usage: RHOFADE® (oxymetazoline hydrochloride) cream, 1%, is indicated for the topical treatment of persistent facial erythema linked to rosacea in adults.
Sorilux (calcipotriene)
(calcipotriene)Mayne Pharma
Usage: SORILUX Foam is indicated for the topical treatment of plaque psoriasis affecting the scalp and body in adults and children aged 4 years and older.